Search

everythinglearnresearchcommunity

for

Search:↓

Basal cell carcinoma cases are rising globally.

Early detection and a multidisciplinary approach are crucial for improving gastric cancer survival rates.

Chemotherapy causes hair loss, nausea, fatigue, and blood issues, but counseling can help manage these effects.

CEC levels may be a useful marker for predicting prostate cancer progression.

Hair helps prevent scalp skin cancer by supporting immune protection.

Blocking the JAK/STAT pathway may help reduce skin sensitivity in Xeroderma pigmentosum.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Radiation therapy for cancer often causes skin problems like redness, dryness, and pain.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

Nanoparticle systems make cancer treatment less toxic.

Medicinal plants have potential as alternative cancer treatments due to their ability to target and kill cancer cells.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

FDG PET/CT scans can change cancer treatment plans for dogs.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Green-synthesized nanoparticles can effectively target cancer cells, reducing side effects and improving treatment.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

The type of tumor suppressor affects the form of skin cancer from hair follicle stem cells.

Selenium shows promise in preventing and controlling prostate cancer.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Self-care strategies, especially diet and lifestyle changes, help manage cancer treatment symptoms.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

Hair can be used to measure cancer-related chemicals noninvasively.